KUSH PARMAR - 11 Jun 2025 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role: Director, 10%+ Owner
Signature: /s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol: TRDA
Transactions as of: 11 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 12 Jun 2025, 08:10:21 UTC
Previous filing: 14 Jun 2024
Next filing: 01 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
PARMAR KUSH	Director, 10%+ Owner	C/O ENTRADA THERAPEUTICS, INC., ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON	/s/ Jared Cohen, as Attorney-in-Fact	12 Jun 2025	0001664281

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRDA	Stock Option (Right to Buy)	Award	$0	+19K		$0.00	19K	11 Jun 2025	Common Stock	19K	$7.90	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 11, 2025 or (ii) the Issuer's next annual meeting of stockholders.